![scored 1630 on moca test scored 1630 on moca test](https://www.frontiersin.org/files/Articles/499662/fmed-07-00447-HTML/image_m/fmed-07-00447-t002.jpg)
Impairment in either domain was modestly correlated with the Fried frailty phenotype (CIB, ρ = 0.177 delayed recall, ρ = 0.170 P = .01 for both), and many phenotypically robust patients also had probable cognitive impairment (24 of 104 on CIB and 9 of 104 on delayed recall). One hundred twenty-seven patients (35.3%) had probable executive dysfunction on the CIB, and 62 (17.2%) had probable impairment in working memory on the 5-word delayed recall. Results Among 420 consecutive patients approached, 360 (85.7%) agreed to undergo frailty assessment (232 men and 128 women mean age, 79.8 years), and 341 of those (94.7%) completed both cognitive screening tests.
![scored 1630 on moca test scored 1630 on moca test](https://i.ytimg.com/vi/wO7n19KMveU/maxresdefault.jpg)
The Fried frailty phenotype and Rockwood cumulative deficit model of frailty were also assessed to characterize participants as robust, prefrail, or frail. A 5-word delayed recall test was used to screen for impairment in working memory. Patients underwent screening for frailty and cognitive dysfunction and were followed up for survival.Įxposures The Clock-in-the-Box (CIB) test was used to screen for executive dysfunction. Objective To determine the prevalence of domain-specific cognitive impairment and its association with overall survival among older patients with blood cancer.ĭesign, Setting, and Participants This prospective observational cohort study included all patients 75 years and older who presented for initial consultation in the leukemia, myeloma, or lymphoma clinics of a large tertiary hospital in Boston, Massachusetts, from February 1, 2015, to March 31, 2017. Little is known about how specific domains of cognitive impairment may be associated with survival among older patients with hematologic cancers. Importance As the population ages, cognitive impairment has promised to become increasingly common among patients with cancer. Shared Decision Making and Communication.Scientific Discovery and the Future of Medicine.Health Care Economics, Insurance, Payment.Clinical Implications of Basic Neuroscience.Challenges in Clinical Electrocardiography.Anemia affects cognition by its direct neurochemical effect and by its indirect effect on behavior.
![scored 1630 on moca test scored 1630 on moca test](https://i.ytimg.com/vi/RzlZB6qlFW0/maxresdefault.jpg)
This, in turn, causes impaired transmitter functions, leading to hypomyelination and delayed neuromaturation. DISCUSSION: Iron deficiency anemia affects cognition by causing a decrease in the iron concentration in the brain, which causes a reduction in the neurotransmitter levels. CONCLUSION: Iron deficiency anemia is significantly correlated with cognition. MoCA scores are more sensitive than MMSE for cognitive assessment. There is significant positive correlation between all parameters of anemia and cognitive scores. Cognitive scores are lesser in females compared to males. RESULTS: In our study prevalence of anemia is 46%. Subjects were grouped into anemic and non anemic groups and further anemic group is sub grouped into mild, moderate and severe as per who criteria. METHODS: For all subjects cognitive assessment scoring was done using MMSE, MoCA cognitive scales and serum samples were sent for determining Hb%, MCH, MCHC, MCV AND S.FERRITIN. MATERIAL: 100 young adults, 67 female and 33 male in age group of 20-22 yrs. AIM: To assess the relationship between iron deficiency anemia and cognitive function in young adults. It has also been found that higher hemoglobin levels results in better CNS functions. Iron is an essential component of brain growth, myelination, and is required for cell differentiation, protein synthesis, hormone production and fundamental aspects of cellular energy metabolism and functioning. Introduction: Iron deficiency anemia is the most common form of anemia.